17 Aug Risk of dopamine dysregulation syndrome (DDS) associated with the use of dopaminergic medicines used for the treatment of Parkinson’s disease (PD).
Posted at 12:37h
in
2021 Nov
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
25/11/2021
File Type:
pdf
Category:
Communication To Health Care Professionals